| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2019 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 15 | Q2 2024 | 34.0% |
| INVESCO QQQ TR | 15 | Q2 2024 | 7.6% |
| REKOR SYSTEMS INC | 15 | Q2 2024 | 2.0% |
| AMAZON COM INC | 15 | Q2 2024 | 1.8% |
| ASSURANT INC | 15 | Q2 2024 | 1.0% |
| INTL GNRL INSURANCE HLDNGS L | 15 | Q2 2024 | 0.6% |
| SPDR S&P 500 ETF TR | 14 | Q2 2024 | 10.2% |
| PURECYCLE TECHNOLOGIES INC | 14 | Q2 2024 | 2.7% |
| ACHIEVE LIFE SCIENCES INC | 14 | Q2 2024 | 0.6% |
| META PLATFORMS INC | 14 | Q2 2024 | 1.1% |
View Shay Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Exela Technologies, Inc. | February 14, 2024 | 523,801 | 8.2% |
| Groupon, Inc. | February 14, 2024 | 478,602 | 1.2% |
| TILLY'S, INC. | February 14, 2024 | 1,926,785 | 8.5% |
| Turtle Beach Corp | February 14, 2024 | 863,628 | 5.0% |
| PharmaCyte Biotech, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Exela Technologies, Inc. | February 13, 2023 | 8,250,000 | 6.8% |
| HyreCar Inc. | February 10, 2022 | 957,546 | 4.4% |
View Shay Capital LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-29 |
View Shay Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.